Alain Gelibter

Alain Gelibter

UNVERIFIED PROFILE

Are you Alain Gelibter?   Register this Author

Register author
Alain Gelibter

Alain Gelibter

Publications by authors named "Alain Gelibter"

Are you Alain Gelibter?   Register this Author

52Publications

752Reads

29Profile Views

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Int J Cancer 2020 04 7;146(7):1917-1929. Epub 2019 Aug 7.

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32583DOI Listing
April 2020

Thyroid disorders in programmed death 1 inhibitor-treated patients: Is previous therapy with tyrosine kinase inhibitors a predisposing factor?

Clin Endocrinol (Oxf) 2020 Mar 1;92(3):258-265. Epub 2020 Jan 1.

Department of Experimental Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.14135DOI Listing
March 2020

'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten : another point of view.

Ann Rheum Dis 2020 Jan 6. Epub 2020 Jan 6.

Arthritis Center, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Sapienza University of Rome, Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2019-216867DOI Listing
January 2020

[Immunotherapy in non-small cell lung cancer patients: back to the future.]

Recenti Prog Med 2019 12;110(12):587-593

Azienda Ospedaliero-Universitaria Sant'Andrea, Roma - Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1701/3278.32517DOI Listing
December 2019

Adjuvant chemotherapy in resected colon cancer: When, how and how long?

Surg Oncol 2019 Sep 2;30:100-107. Epub 2019 Jul 2.

Department of Radiology, Oncology and Pathology, Policlinico Umberto, I Sapienza University of Rome, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09607404183035
Publisher Site
http://dx.doi.org/10.1016/j.suronc.2019.06.003DOI Listing
September 2019

TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway.

Cancer Immunol Res 2018 06 26;6(6):711-722. Epub 2018 Apr 26.

Laboratory of Tumor Immunology and Cell Therapy, Department of Experimental Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-17-0594DOI Listing
June 2018

Coexistence of three EGFR mutations in an NSCLC patient: A brief report.

Int J Biol Markers 2018 Jun 1:1724600818782200. Epub 2018 Jun 1.

1 Dipartimento di Medicina Molecolare, Sapienza Università di Roma, Roma, Italia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1724600818782200DOI Listing
June 2018

Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.

Oncology 2017 14;93(1):62-66. Epub 2017 Apr 14.

Division of Medical Oncology, Department of Radiological, Oncological, and Pathological Sciences, "Sapienza" University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000464328DOI Listing
October 2017

Use of Adjuvant Chemotherapy After Surgery in Patients With Colon Cancer.

JAMA Surg 2017 09;152(9):895

Oncology Unit, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2017.1617DOI Listing
September 2017

Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.

Expert Opin Drug Discov 2013 Nov 3;8(11):1381-97. Epub 2013 Oct 3.

Regina Elena National Cancer Institute, Division of Medical Oncology A , Via Elio Chianesi 53, 00144, Rome , Italy +39 06 52666919 ; +39 06 52665637 ; ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17460441.2013.843523DOI Listing
November 2013

Emerging pathways and future targets for the molecular therapy of pancreatic cancer.

Expert Opin Ther Targets 2011 Oct 7;15(10):1183-96. Epub 2011 Aug 7.

Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.2011.607438DOI Listing
October 2011

Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.

Oncology 2009 26;76(4):254-61. Epub 2009 Feb 26.

Department of Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000205388DOI Listing
April 2009

Bevacizumab: one treatment for all the seasons?

J Clin Oncol 2008 Jan;26(3):511; author reply 511-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.0292DOI Listing
January 2008

Severe rhabdomyolysis associated with pemetrexed-based chemotherapy.

Lancet Oncol 2006 Apr;7(4):353

Division of Medical Oncology A, Regina Elena Cancer Institute, Via Elio Chianesi, 53, 00144 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(06)70662-3DOI Listing
April 2006

Impact of gefitinib ('Iressa') treatment on the quality of life of patients with advanced non-small-cell lung cancer.

J Cancer Res Clin Oncol 2005 Dec 15;131(12):783-8. Epub 2005 Nov 15.

Division of Medical Oncology A, Regina Elena Cancer Institute, Via Elio Chianesi, 53, 00144, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-005-0029-9DOI Listing
December 2005

PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients.

Anticancer Res 2004 Sep-Oct;24(5B):3147-51

Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
November 2004

New approaches to prevent intestinal toxicity of irinotecan-based regimens.

Cancer Treat Rev 2004 Oct;30(6):555-62

Division of Medical Oncology, San Pietro Hospital, FBF International, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2004.05.002DOI Listing
October 2004

Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma.

Cancer 2004 Jul;101(1):133-8

Divisions of Medical Oncology "A" and "C", Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20338DOI Listing
July 2004